ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Unlocking CSU pathogenesis to shape the future treatment landscape"
Episode Synopsis
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.
The experts:
Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada
Prof. David Khan – Southwestern Medical Center, University of Texas, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/
Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.
The experts:
Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada
Prof. David Khan – Southwestern Medical Center, University of Texas, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/
In God we trust